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Resolution  
Threshold of  
Current Molecular 
Epidemiology  
of Diphtheria
“The fox who longed for 
grapes, beholds with pain
The tempting clusters were 
too high to gain;
Grieved in his heart he forced 
a careless smile,
And cried, ‘They’re sharp 
and hardly worth my while.’”
(Aphra Behn, 1687, after Aesop’s 
The Fox and the Grapes)
To the Editor: Diphtheria is 
an extremely rare disease in Europe 
but remains a major health issue in 
developing countries (1–3). In recent 
years, steady progress has been made 
toward understanding the factors of 
pathogenicity of its causative agent 
(Corynebacterium diphtheriae). In 
contrast, remarkable advances in its ba-
sic genomics have not been sufficiently 
translated into the molecular epidemi-
ology of diphtheria. A recent report by 
Zasada (4) offers an apt opportunity to 
take a new look at this issue.
The current genotyping reper-
toire of C. diphtheriae includes several 
methods but those most frequently used 
are classical ribotyping and pulsed-
field gel electrophoresis (PFGE). More 
recently, a multilocus sequence typing 
(MLST) scheme for C. diphtheriae was 
developed (5). Compared with ribotyp-
ing, PFGE, and other methods based on 
analysis of banding profiles, MLST re-
sults are digital, unambiguous, and por-
table. MLST discrimination of 150 iso-
lates from 18 countries and spanning 50 
years was “in accordance with previous 
ribotyping data, and clonal complexes 
associated with disease outbreaks were 
clearly identified by MLST” (5).
In the report by Zasada (4), all 
3 recommended methods (PFGE, 
MLST, and ribotyping) were used to 
genotype 25 nontoxigenic C. diphthe-
riae isolates from Poland. The author 
concluded that these isolates “repre-
sent a single clone despite isolation … 
in different part of the country over a 
9-year period” and raised the question 
of whether a single clone of C. diphthe-
riae is circulating in Poland (4). These 
isolates are related genetically, but do 
they represent a truly single clone or 
might they be further discriminated? 
Their circulation in Poland may be 
caused by their high pathogenicity, but 
also (or instead) it might reflect their 
endemic, historical prevalence in this 
country. I believe that these questions 
are unlikely to be answered by the in-
ternationally agreed-upon methods for 
C. diphtheriae typing because of their 
insufficient resolution: the discrimina-
tory power of MLST does not exceed 
that of ribotyping (5).
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Two in silico–inspired approach-
es have recently been pursued toward 
more precise molecular genetics and 
epidemiology of diphtheria. The first 
approach is based on whole-genome 
sequencing (WGS). After years of 
stagnation, the number of complete C. 
diphtheriae genomes has finally start-
ed to increase: currently 13 complete 
and 3 draft genomes are available in 
GenBank (as of April 14, 2014). The 
second approach is locus oriented 
and makes use of the repetitive DNA 
sequences, namely, variable number 
tandem repeats (VNTR) and clustered, 
regularly interspaced short palindrom-
ic repeats (CRISPR) loci.
A study in Poland showed a dis-
criminatory capacity of some of the 
VNTR loci in C. diphtheriae (6), al-
though preliminary results were not 
compared with those from other typ-
ing methods. CRISPR loci in C. diph-
theriae have been studied in more 
detail and CRISPR-based spoligotyp-
ing showed a high level of discrimina-
tion for an epidemic clone in Russia 
and Belarus (7,8). In particular, 156 
isolates from Russia of the epidemic 
clone (classical ribotypes Sankt-Pe-
tersburg and Rossija) were subdivided 
into 45 spoligotypes (7).
Further studies underlined the 
limitations of CRISPR-based typing: 
the 3 described CRISPR loci are not 
present simultaneously in all isolates; 
and most strains have unique spacers 
at the leader part of the array, which 
indicates their independent evolu-
tion after they diverged from a com-
mon ancestor (9). Accordingly, Sangal 
et al. suggested that CRISPR-based 
typing might not necessarily provide 
information on evolutionary relation-
ships between different strains, but it 
might offer a high level of discrimina-
tion to study local epidemiology (9).
Recent advances in C. diphthe-
riae genomics concern an increasing 
number of complete genomes in Gen-
Bank, development of new ideas (e.g., 
revisiting biochemical subdivision into 
biovars) (10), and development of new 
typing schemes (MLST, VNTR, and 
spoligotyping). Nevertheless, in spite 
of lack of genetic support, biochemical 
classification into biovars is still un-
critically used. In spite of other demon-
strated or potential tools (e.g., CRISPR, 
VNTR), classical or new methods (all 
with limited resolution) are still used 
in many studies, both global and local. 
In spite of many available complete 
genomes, this wealth of information 
has not been translated into a WGS-in-
formed high-resolution typing scheme. 
It might be sufficient to sequence all 3 
CRISPR/cas loci in all strains studied 
by Zasada (4) to gain some insight into 
their relatedness and possible spatio-
temporal evolution. A phylogenetically 
more robust, albeit more expensive, so-
lution would be using WGS analysis to 
achieve the same objective.
In conclusion, molecular epide-
miology of diphtheria would defi-
nitely benefit from implementation 
of more precise molecular genetics. 
First, WGS (or at least core genome) 
analysis might offer a broader range of 
possible general solutions from global 
tracing of large clonal clusters (current 
threshold) toward fine-tuned strain 
discrimination. At the same time, a 
multicenter evaluation of recently de-
veloped inexpensive and discrimina-
tory VNTR and CRISPR methods is 
warranted to see if and how they could 
complement regional surveillance.
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